Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

492 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Emergence of transmissible SARS-CoV-2 variants with decreased sensitivity to antivirals in immunocompromised patients with persistent infections.
Nooruzzaman M, Johnson KEE, Rani R, Finkelsztein EJ, Caserta LC, Kodiyanplakkal RP, Wang W, Hsu J, Salpietro MT, Banakis S, Albert J, Westblade LF, Zanettini C, Marchionni L, Soave R, Ghedin E, Diel DG, Salvatore M. Nooruzzaman M, et al. Among authors: rani r. Nat Commun. 2024 Sep 18;15(1):7999. doi: 10.1038/s41467-024-51924-3. Nat Commun. 2024. PMID: 39294134 Free PMC article.
Emergence of transmissible SARS-CoV-2 variants with decreased sensitivity to antivirals in immunocompromised patients with persistent infections.
Nooruzzaman M, Johnson KEE, Rani R, Finkelsztein EJ, Caserta LC, Kodiyanplakkal RP, Wang W, Hsu J, Salpietro MT, Banakis S, Albert J, Westblade L, Zanettini C, Marchionni L, Soave R, Ghedin E, Diel DG, Salvatore M. Nooruzzaman M, et al. Among authors: rani r. medRxiv [Preprint]. 2024 Jun 18:2024.06.14.24308523. doi: 10.1101/2024.06.14.24308523. medRxiv. 2024. Update in: Nat Commun. 2024 Sep 18;15(1):7999. doi: 10.1038/s41467-024-51924-3 PMID: 38946967 Free PMC article. Updated. Preprint.
PreVenTB trial: protocol for evaluation of efficacy and safety of two vaccines VPM1002 and Immuvac (Mw) in preventing tuberculosis (TB) in healthy household contacts of newly diagnosed sputum smear-positive pulmonary TB patients: phase III, randomised, double-blind, three-arm placebo-controlled trial.
Singh M, Mehendale S, Guleria R, Sarin R, Tripathy S, Gangakhedkar RR, Katoch K, Pandey RM, Panda S, Pati S, Mohapatra PR, Joshi S, Narasimhaiah S, Kodan P, Bhaskar S, Rani R, Khan AM, Swaminathan S; PreVenTB Trial Team. Singh M, et al. Among authors: rani r. BMJ Open. 2024 Aug 31;14(8):e082916. doi: 10.1136/bmjopen-2023-082916. BMJ Open. 2024. PMID: 39645271 Free article.
492 results